Strong Revenue Growth
BioHarvest Sciences reported a strong revenue growth of 99% year-over-year, achieving $25.2 million for the full year of 2024. Q4 revenue grew 62% year-over-year to $7.3 million.
Increase in Gross Margins
Gross margins for the fourth quarter of 2024 increased by 600 basis points to 57% from 51% a year ago, with a year-over-year improvement of 1,000 basis points from 45% in 2023 to 55% in 2024.
Subscription and Product Diversification Success
VINIA, the flagship product, has over 50,000 active subscribers, with 90% of Vinia.com revenue derived from subscriptions. The product lineup has expanded to include superfood coffees and teas.
Operating Leverage and Cost Management
Full year general and administrative expenses decreased by 1.8% year-over-year despite doubling the revenue base. The operating expenses decreased to 80% of revenue in Q4 2024 from 107% a year ago.
CDMO Business Expansion
BioHarvest signed multiple CDMO customers, including a marquee partnership with Tate & Lyle to develop next-generation plant-based sweeteners. Multiple deals are in the pipeline.